DK0433239T3 - Anvendelse af naphthoxaziner - Google Patents

Anvendelse af naphthoxaziner

Info

Publication number
DK0433239T3
DK0433239T3 DK90810968.9T DK90810968T DK0433239T3 DK 0433239 T3 DK0433239 T3 DK 0433239T3 DK 90810968 T DK90810968 T DK 90810968T DK 0433239 T3 DK0433239 T3 DK 0433239T3
Authority
DK
Denmark
Prior art keywords
naphthoxazines
schaemia
cerebral
stroke
compounds
Prior art date
Application number
DK90810968.9T
Other languages
Danish (da)
English (en)
Inventor
Jean-Marie Vigouret
Joachim Nozulak
Andre Sauter
Original Assignee
Sandoz Ltd
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898928316A external-priority patent/GB8928316D0/en
Priority claimed from DE19904003262 external-priority patent/DE4003262A1/de
Application filed by Sandoz Ltd, Sandoz Ag filed Critical Sandoz Ltd
Application granted granted Critical
Publication of DK0433239T3 publication Critical patent/DK0433239T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
DK90810968.9T 1989-12-14 1990-12-11 Anvendelse af naphthoxaziner DK0433239T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898928316A GB8928316D0 (en) 1989-12-14 1989-12-14 Improvements in or relating to organic compounds
DE19904003262 DE4003262A1 (de) 1990-02-03 1990-02-03 Neues naphthoxazin, seine herstellung und verwendung

Publications (1)

Publication Number Publication Date
DK0433239T3 true DK0433239T3 (da) 1995-01-16

Family

ID=25889734

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90810968.9T DK0433239T3 (da) 1989-12-14 1990-12-11 Anvendelse af naphthoxaziner

Country Status (15)

Country Link
US (1) US5190941A (hu)
EP (1) EP0433239B1 (hu)
JP (1) JPH0825880B2 (hu)
KR (1) KR0182276B1 (hu)
AT (1) ATE113040T1 (hu)
AU (1) AU639512B2 (hu)
CA (1) CA2032132A1 (hu)
CY (1) CY2065B1 (hu)
DE (1) DE69013476T2 (hu)
DK (1) DK0433239T3 (hu)
ES (1) ES2063328T3 (hu)
HK (1) HK1000244A1 (hu)
HU (1) HU214591B (hu)
IE (1) IE66143B1 (hu)
PT (1) PT96178B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000124A1 (en) * 1992-06-22 1994-01-06 Eckard Weber Glycine receptor antagonists and the use thereof
DE4329776A1 (de) * 1993-09-03 1995-03-09 Sandoz Ag Naphthoxazine, ihre Herstellung und Verwendung
BRPI0920246A2 (pt) 2008-10-17 2017-06-27 Winconsin Alumni Res Foundation método de preparação de alfa-beta peptídios biologicamente ativos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540691A (en) * 1984-04-13 1985-09-10 Nelson Research & Development Co. Dopamine agonists and use thereof
HU193979B (en) * 1984-06-12 1987-12-28 Sandoz Ag Process for producing naphtoxazine derivatives and pharmaceutical compositions containing them
EP0233728A1 (en) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazine derivatives their production and use

Also Published As

Publication number Publication date
CY2065B1 (en) 1998-06-12
ES2063328T3 (es) 1995-01-01
CA2032132A1 (en) 1991-06-15
PT96178B (pt) 1998-04-30
DE69013476T2 (de) 1995-05-04
IE66143B1 (en) 1995-12-13
PT96178A (pt) 1991-09-30
ATE113040T1 (de) 1994-11-15
KR910011261A (ko) 1991-08-07
HU908017D0 (en) 1991-06-28
JPH03271223A (ja) 1991-12-03
HUT57749A (en) 1991-12-30
KR0182276B1 (ko) 1999-05-01
AU639512B2 (en) 1993-07-29
JPH0825880B2 (ja) 1996-03-13
EP0433239B1 (en) 1994-10-19
DE69013476D1 (de) 1994-11-24
HU214591B (hu) 1998-04-28
AU6797590A (en) 1991-06-20
EP0433239A1 (en) 1991-06-19
US5190941A (en) 1993-03-02
HK1000244A1 (en) 1998-02-13
IE904497A1 (en) 1991-06-19

Similar Documents

Publication Publication Date Title
DE59407626D1 (de) Sulfonylaminopyrimidine, ihre Herstellung und Verwendung als Heilmittel
DK0459256T3 (da) Oxazolidiononer
DE69424009T2 (de) Verwendung von (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid zur Herstellung eines Medikaments zur Behandlung von Angst
DK0532515T3 (da) Fremstilling af substituerede piperidiner
ES2081636T3 (es) Preparacion de piperidinas sustituidas.
PT97259A (pt) Processo para a estabilizacao de isotiazolonas com fenoxialcanois
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
ITMI931012A1 (it) Composti spiro-piranici dotati di caratteristiche fotocromatiche
DK0433239T3 (da) Anvendelse af naphthoxaziner
FI924477A0 (fi) Foerfarande foer diastereoselektiv reduktiv pinakolkoppling av homochirala a-aminoaldehyder
DE59104132D1 (de) Verwendung von 2-n-Alkyl-1,2-benzisothiazolin-3-onen als technische Mikrobiozide.
DE68911237T2 (de) Nichtionische Trijodbenzin-Verbindungen und diese enthaltende Kontrastmittel.
DK0623131T3 (da) Alkylderivater af trazodon med CNS-aktivitet
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
SE8700566L (sv) Tetracykliska kinazolinoner
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
DE58909089D1 (de) Verwendung von Myricetin-3-0-beta-D-glucuronid als Arzneimittel.
ATE111099T1 (de) Ergolinderivate.
FI882388A (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.